Haoran Dong

604 total citations
24 papers, 379 citations indexed

About

Haoran Dong is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Haoran Dong has authored 24 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Haoran Dong's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Traditional Chinese Medicine Analysis (3 papers). Haoran Dong is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Traditional Chinese Medicine Analysis (3 papers). Haoran Dong collaborates with scholars based in China, Canada and United States. Haoran Dong's co-authors include Litong Yao, Mengshen Wang, Xiangyu Sun, Xinyan Li, Mozhi Wang, Tie Sun, Yingying Xu, Jingyi Guo, Xueting Yu and Yingying Xu and has published in prestigious journals such as Journal of Ethnopharmacology, International Journal of Environmental Research and Public Health and Signal Transduction and Targeted Therapy.

In The Last Decade

Haoran Dong

18 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haoran Dong China	8	240	176	98	66	28	24	379
Paradesi Naidu Gollavilli United States	11	284 1.2×	104 0.6×	93 0.9×	82 1.2×	25 0.9×	12	457
Mozhi Wang China	10	219 0.9×	194 1.1×	125 1.3×	41 0.6×	27 1.0×	24	395
Yangwei Xu China	6	231 1.0×	136 0.8×	117 1.2×	111 1.7×	29 1.0×	12	440
Haifeng Yang China	13	220 0.9×	90 0.5×	63 0.6×	30 0.5×	35 1.3×	27	391
Xinming Chi China	11	246 1.0×	126 0.7×	58 0.6×	53 0.8×	21 0.8×	19	351
Christian Orlowski Australia	6	227 0.9×	66 0.4×	63 0.6×	49 0.7×	35 1.3×	9	396
Xiaoming Lin China	11	312 1.3×	181 1.0×	42 0.4×	44 0.7×	39 1.4×	35	453
Silvia Cecilia Pacheco-Velázquez Mexico	11	310 1.3×	207 1.2×	83 0.8×	27 0.4×	25 0.9×	23	476
Hongjuan Cui China	11	305 1.3×	89 0.5×	59 0.6×	40 0.6×	35 1.3×	19	405
Farzad Rahmani Iran	10	229 1.0×	148 0.8×	66 0.7×	25 0.4×	34 1.2×	15	375

Countries citing papers authored by Haoran Dong

Since Specialization

Citations

This map shows the geographic impact of Haoran Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoran Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoran Dong more than expected).

Fields of papers citing papers by Haoran Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoran Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoran Dong. The network helps show where Haoran Dong may publish in the future.

Co-authorship network of co-authors of Haoran Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Haoran Dong. A scholar is included among the top collaborators of Haoran Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoran Dong. Haoran Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Haoran, Danfeng Hu, Jingqiu Zhang, et al.. (2025). Pan-Cancer Analysis of ANO6 and Experimental Validation in Metastatic Melanoma. Biochemical Genetics. 64(1). 1032–1050. 1 indexed citations

Su, Zhong, Lixia Yang, Haoran Dong, et al.. (2025). Stress experiences among older Chinese immigrants in Canada during the COVID-19 pandemic: A qualitative study. S1(1). 42–51.

Dong, Haoran, Jie Lei, Kai‐Yuan Fu, Yi Zhang, & Yang He. (2025). “Modified arthroscopic disc repositioning and suturing technique for the treatment of TMJ anterior disc displacement without reduction: A technical note”. Journal of Cranio-Maxillofacial Surgery. 53(4). 347–354.

Yang, Minhui, Lu Wang, Lixia Yang, et al.. (2025). Spatial Mobility Change Among Older Chinese Immigrants During the COVID-19 Pandemic: The Role of Physical, Social, and Virtual Environmental Factors. International Journal of Environmental Research and Public Health. 22(3). 406–406. 2 indexed citations

Dong, Haoran, et al.. (2025). “The effect of disc repositioning on regenerative condylar bone remodelling in juvenile patients with temporomandibular joint osteoarthritis: a retrospective cohort study”. Clinical Oral Investigations. 29(2). 104–104.

Zhang, Qiang, Yumeng Li, Hengjun Zhang, et al.. (2025). Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial. Signal Transduction and Targeted Therapy. 10(1). 169–169. 3 indexed citations

Liu, Shiyang, Litong Yao, Haoran Dong, et al.. (2025). Efficacy and safety of neoadjuvant ICI combined with chemotherapy in breast cancer from the perspective of a privileged population: a systematic review and meta-analysis. International Journal of Surgery. 111(7). 4726–4735.

Dong, Haoran, et al.. (2024). ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis. Cancer Biology and Medicine. 21(7). 1–30. 7 indexed citations

Li, Caixia, Lifeng Wang, Haoran Dong, et al.. (2024). Erythrophagocytosis-induced ferroptosis contributes to pulmonary microvascular thrombosis and thrombotic vascular remodeling in pulmonary arterial hypertension. Journal of Thrombosis and Haemostasis. 23(1). 158–170. 6 indexed citations

10.

Wu, Chen, Shiyang Liu, Litong Yao, et al.. (2024). Primary tumor resection in de novo metastatic breast cancer from an oligometastatic perspective: A systematic review and meta-analysis. iScience. 27(12). 111224–111224.

11.

Yao, Litong, Shuang Li, Mengshen Wang, et al.. (2021). An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine. Frontiers in Oncology. 11. 651809–651809. 4 indexed citations

12.

Yao, Litong, Mozhi Wang, Mengshen Wang, et al.. (2021). The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study. Cancer Biology and Medicine. 19(5). 755–767. 6 indexed citations

13.

Zhao, Di, et al.. (2021). The pharmacokinetic study of Tanreqing and the interaction with cefixime in rat model of pneumonia by validated UPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 209. 114484–114484. 2 indexed citations

14.

Li, Xinyan, Litong Yao, Mozhi Wang, et al.. (2020). Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer. Journal of Breast Cancer. 23(4). 410–410. 1 indexed citations

15.

Sun, Xiangyu, Mozhi Wang, Mengshen Wang, et al.. (2020). Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential. Frontiers in Cell and Developmental Biology. 8. 651–651. 53 indexed citations

16.

Li, Jiansheng, Yange Tian, Peng Zhao, et al.. (2020). Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling. Journal of Ethnopharmacology. 257. 112796–112796. 30 indexed citations

17.

Dong, Haoran, Litong Yao, Mozhi Wang, et al.. (2020). Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?—a meta-analysis of randomized controlled trials. Translational Cancer Research. 9(11). 7034–7043. 12 indexed citations

18.

Sun, Xiangyu, Mozhi Wang, Mengshen Wang, et al.. (2020). Metabolic Reprogramming in Triple-Negative Breast Cancer. Frontiers in Oncology. 10. 428–428. 156 indexed citations

19.

Sun, Xiangyu, Mozhi Wang, Mengshen Wang, et al.. (2020). Exploring the Metabolic Vulnerabilities of Epithelial–Mesenchymal Transition in Breast Cancer. Frontiers in Cell and Developmental Biology. 8. 655–655. 21 indexed citations

20.

Tian, Yange, Ya Li, Jiansheng Li, et al.. (2017). Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2017(1). 1768243–1768243. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact